1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. LUPIN LTD.
2287.40 35.00 (1.55%)
1.3M
NSE+BSE Volume

NSE 19 May, 2026 3:31 PM (IST)

Watchlist

Portfolio

Alert

US FDA Approval
Lupin's ANDA for Revefenacin inhalation solution gets US FDA nod, with sales of $261 mn in FY26 See details